Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis.

This publication has 14 references indexed in Scilit:

• Use of omeprazole during pregnancy — no hazard demonstrated in 955 infants exposed during pregnancy
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
• Gastroesophageal reflux disease in pregnancy
  Current Treatment Options in Gastroenterology, 2001
• Use of Cimetidine, Omeprazole, and Ranitidine in Pregnant Women and Pregnancy Outcomes
  American Journal of Epidemiology, 1999
• The safety of proton pump inhibitors in pregnancy
  Alimentary Pharmacology & Therapeutics, 1999
• Omeprazole for peptic ulcer disease in pregnancy.
  Digestion, 1998
• Delivery outcome after the use of acid‐suppressing drugs in early pregnancy with special reference to omeprazole
  BJOG: An International Journal of Obstetrics and Gynaecology, 1998
• Pharmacoeconomic applications of meta-analysis for single groups using antifungal onychomycosis lacquers as an example
  Clinical Therapeutics, 1997
• Intravenous Administration of the Proton Pump Inhibitor Omeprazole Reduces the Risk of Acid Aspiration at Emergency Cesarean Section
  Anesthesia & Analgesia, 1994
• Effect of single‐dose omeprazole on intragastric acidity and volume during obstetric anaesthesia
  Anaesthesia, 1989
• Placental Transfer of Omeprazole in Maternal and Fetal Sheep
  Developmental Pharmacology and Therapeutics, 1986